Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
WADA placed semaglutide (Ozempic/Wegovy) on its Monitoring Program in 2024 , and from 1 January 2026 it added markers of tirzepatide (Mounjaro/Zepbound) too both now monitored in-competition and out-of-competition
The active ingredient works the same way in your body whether it comes from a brand manufacturer or a compounding facility
Starting at $249/month, this affordable solution includes medication delivery and monthly telemedicine visits for personalized care
It reduces appetite, improves insulin secretion, and increases energy expenditure through multi-hormonal receptor activation
seek medical advice if unable to maintain adequate fluid intake
Aim for 25-38 g of fiber daily, increasing intake gradually to minimize gastrointestinal side effects
